Home » Topics » Infection, BioWorld Science

Infection, BioWorld Science
RSS

Combination malaria vaccine enters phase I

Dec. 3, 1997

Second-generation 2-5A antisense drug with broad-spectrum anti-RSV activity

Dec. 2, 1997

New erythromycins discovered at Roussel Uclaf

Nov. 27, 1997

Milestone reached in antiinfectives alliance

Nov. 26, 1997

BioChem Pharma patents agents for CMV

Nov. 25, 1997

Cytokine combination demonstrates antiinfective activity in mice

Nov. 25, 1997

HMR and Scriptgen enter antifungal drug discovery alliance

Nov. 25, 1997

Development of new quinolone from Toyama advances

Nov. 24, 1997

Antifungal activity of KP-103 under evaluation

Nov. 24, 1997

FDA advisory committee recommends approval of Rocephin for AOM

Nov. 24, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 30, 2025.
Today's news in brief
Briefs
BioWorld MedTech briefs for Jan. 30, 2026.
Brain-derived tau in blood predicts stroke severity and outcome
BioWorld Science
Brain-derived tau, a protein that is exclusive to the brain and detectable in the blood, could serve as an indicator of brain damage after an ischemic stroke. The...
Centessa’s CNT-9982 shows promise for MDD
BioWorld Science
Orexin OX2 receptor agonists have demonstrated the ability to enhance wakefulness in rodent models, as well as in nonhuman primates and patients with narcolepsy...
First-in-class ADC targeting DEM-TXX shows high preclinical efficacy
BioWorld Science
Researchers at DEM Biopharma Inc. reported preclinical findings demonstrating the efficacy of DEM-301, a bifunctional antibody-drug conjugate (ADC) engineered to...